What should we evaluate in an older adult with cancer?
DOI:
https://doi.org/10.51987/revhospitalbaires.v41i4.124Keywords:
elderly, geriatric assessment, frailty, cancer, sarcopenia, abilities of daily livingAbstract
As the population grows, there will be more cancer diagnoses in the elderly population. This group, due to its heterogeneity and comorbidities different from those of young adults, requires a specific and individualized assessment. The geriatric assessment and multidisciplinary work, together, would help in decision-making in order to prioritize the quality of life of each patient and optimize management of the vulnerable patients.
Downloads
References
- Ribeiro IA, Lima LR, Volpe CRG, et al. Frailty syndrome in the elderly in elderly with chronic diseases in primary care. Rev Esc Enferm USP. 2019;53:e03449. https://doi.org/10.1590/S1980-220X2018002603449. Errata en: Rev Esc Enferm USP. 2021;54:e03568. DOI: https://doi.org/10.1590/s1980-220x2018002603449
- Soto-Perez-de-Celis E, Li D, Yuan Y, et al. Functional versus chronological age: geriatric assessments to guide decision making in older patients with cancer. Lancet Oncol. 2018;19(6):e305-e316. https://doi.org/10.1016/S1470-2045(18)30348-6. DOI: https://doi.org/10.1016/S1470-2045(18)30348-6
- Hernandez Torres C, Hsu T. Comprehensive geriatric assessment in the older adult with cancer: a review. Eur Urol Focus. 2017;3(4-5):330-339. https://doi.org/10.1016/j.euf.2017.10.010. DOI: https://doi.org/10.1016/j.euf.2017.10.010
- Handforth C, Clegg A, Young C, et al. The prevalence and outcomes of frailty in older cancer patients: a systematic review. Ann Oncol. 2015;26(6):1091-1101. https://doi.org/10.1093/annonc/mdu540. DOI: https://doi.org/10.1093/annonc/mdu540
- Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146-156. https://doi.org/10.1093/gerona/56.3.m146. DOI: https://doi.org/10.1093/gerona/56.3.M146
- O'Donovan A, Leech M. Personalised treatment for older adults with cancer: the role of frailty assessment. Tech Innov Patient Support Radiat Oncol. 2020;16:30-38. https://doi.org/10.1016/j.tipsro.2020.09.001. DOI: https://doi.org/10.1016/j.tipsro.2020.09.001
- Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31. https://doi.org/10.1093/ageing/afy169. Errata en: Age Ageing. 2019;48(4):601. DOI: https://doi.org/10.1093/ageing/afz046
- Dunne RF, Loh KP, Williams GR, et al. Cachexia and sarcopenia in older adults with cancer: a comprehensive review. Cancers (Basel). 2019;11(12):1861. https://doi.org/10.3390/cancers11121861. DOI: https://doi.org/10.3390/cancers11121861
- Nightingale G, Battisti NML, Loh KP, et al. Perspectives on functional status in older adults with cancer: an interprofessional report from the International Society of Geriatric Oncology (SIOG) nursing and allied health interest group and young SIOG. J Geriatr Oncol. 2021;12(4):658-665. https://doi.org/10.1016/j.jgo.2020.10.018. DOI: https://doi.org/10.1016/j.jgo.2020.10.018
-Wirtz D, Kohlhof H. The geriatric patient: special aspects of peri-operative management. EFORT Open Rev. 2019;4(6):240-247. https://doi.org/10.1302/2058-5241.4.180087. DOI: https://doi.org/10.1302/2058-5241.4.180087
- Extermann M, Boler I, Reich RR, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. 2012;118(13):3377-3386. https://doi.org/10.1002/cncr.26646. DOI: https://doi.org/10.1002/cncr.26646
- Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011;29(25):3457-3465. https://doi.org/10.1200/JCO.2011.34.7625. DOI: https://doi.org/10.1200/JCO.2011.34.7625
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Instituto Universitario Hospital Italiano de Buenos Aires
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
